Veracyte, Inc. (VCYT) Cash Flow Statement
Veracyte, Inc. (VCYT) generated $178.4M of operating cash flow over the twelve months to 2026-06-30, spent $12.4M on capital expenditure and had free cash flow of $166.0M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
VCYTVeracyte, Inc.Follow VCYT — free
—
Price chart with a free account
- Market cap
- 3.9B
- P/E TTM
- 34.2
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 | -0.01 | -0.00 | -0.01 | -0.03 | 0.01 | 0.04 | 0.08 | 0.14 | 0.18 | |
| Capital expenditure | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | |
| Free cash flow | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 | -0.04 | -0.00 | 0.03 | 0.06 | 0.13 | 0.17 | |
| Stock-based compensation | — | — | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | 0.04 | — |
USD billions · SEC XBRL
Veracyte, Inc. — questions
- What is Veracyte, Inc.'s operating cash flow?
- $178.4M over the twelve months to 2026-06-30.
- How much does Veracyte, Inc. spend on capital expenditure?
- $12.4M over the twelve months to 2026-06-30.
- What is Veracyte, Inc.'s free cash flow?
- $166.0M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Veracyte, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.